1.
ClinicalTrials.gov; 25/10/2021; TrialID: NCT05094648
Clinical Trial Register
| ICTRP | ID: ictrp-NCT05094648
ABSTRACT
Condition:
High Flow Nasal TherapyIntervention:
Other: high flow nasal therapyPrimary outcome:
predictors of success of high flow nasal therapy in covid 19 patientsCriteria:
Inclusion Criteria:
- All Patients above 18 y old that will be diagnosed as COVID 19 based on PCR testing,
who fulfil criteria that indicate need for high flow nasal therapy.
Exclusion Criteria:
- o Children less than 18 y old
- Oropharyngeal and Nasopharyngeal swap negative patients
- Patients who will refuse inclusion in the study